batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. SpringWorks gets an early second approval 12 February 2025 Enhertu goes pivotal in ovarian 12 February 2025 Tightening the Bolt on a questionable strategy 12 February 2025 Bristol touts a marginal zone win 10 February 2025 Two more reasons for GSK to be wary of Tim-3 6 February 2025 GSK gets a lung cancer PARP delay 5 February 2025 Turnstone faces TIL reality 5 February 2025 Pfizer makes haste to catch up in PD-L1 5 February 2025 Load More